Table 1.

Oxaliplatin perfusion.

Patient (sex)/diagnosis	Weight (kg)	Length (cm)	Surface area (m2)	Dose of oxaliplatin during HIPEC (mg)
Female/CRC with PC	48	158	1.47	600
Male/CRC with PC	96	178	2.14	960
Male/CRC with PC	87	185	2.11	960
Male/CRC with PC	82	173	1.96	890
Male/CRC with PC	80	170	1.91	870
Female/CRC with PC	72	164	1.78	380

CRC: Colorectal cancer; PC: Peritoneal carcinomatosis; HIPEC: hyperthermic intraperitoneal chemotherapy.